BDBM50331642 5-(4-(2-(4-(1-allyl-3-(4-(trifluoromethyl)benzyl)ureido)piperidin-1-yl)ethyl)-4-(3-fluorophenyl)piperidine-1-carbonyl)-N-tert-butyl-4-chloro-2-fluorobenzenesulfonamide::CHEMBL1288880

SMILES CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(CC3)N(CC=C)C(=O)NCc3ccc(cc3)C(F)(F)F)(CC2)c2cccc(F)c2)c(Cl)cc1F

InChI Key InChIKey=APZBZVHKLFMHLS-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50331642   

TargetC-C chemokine receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331642(5-(4-(2-(4-(1-allyl-3-(4-(trifluoromethyl)benzyl)u...)
Affinity DataIC50: 6.90nMAssay Description:Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetC-C chemokine receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331642(5-(4-(2-(4-(1-allyl-3-(4-(trifluoromethyl)benzyl)u...)
Affinity DataIC50: 42nMAssay Description:Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed